AUS
NZ
UK
CA
USA
IND
Healthcare
Animalcare Group Announces £20 Million Fundraise to Support Strategic Acquisition
December 03, 2024 10:35 AM GMT| By Team Kalkine MediaHighlights,Animalcare Group Plc is raising £20 million through a non-pre-emptive placing of shares at 232.5 pence, a 5.1% discount on the December 2 market price.,The funds will partly finance the acquisition of Randlab, an Australian-based equine ve...
EMV Capital Announces £1.5 Million Fundraising at Premium, Boosting Strategic Growth Plans
December 03, 2024 10:35 AM GMT| By Team Kalkine MediaHighlights:,Premium Fundraising Success:,EMV Capital secures £1.5 million in funding at a 15% premium to the previous close, showcasing strong market confidence.,Operational and Strategic Investments:,Proceeds will enhance operational efficiency, bol...
Feedback plc (LON:FDBK) Insider Philipp Prince Sells 20,232 Shares Amid Price Decline
December 03, 2024 08:55 AM GMT| By Team Kalkine MediaHighlights,Philipp Prince, an insider at Feedback plc (FDBK), sells 20,232 shares.,Feedback's stock shows a notable drop, with a 52-week low of GBX 19.,The company’s focus is on providing medical imaging software solutions.,Feedback plc Insider Activ...
Faron Pharmaceuticals Advances Cancer Therapy with UK Regulatory Approvals
December 02, 2024 10:08 AM GMT| By Team Kalkine MediaHighlights:,Regulatory Approval:,The UK Medicines and Healthcare products Regulatory Agency (MHRA) approves Faron Pharmaceuticals’ BEXMAB trial for cancer immunotherapy.,Innovation Passport:,Bexmarilimab earns the prestigious ILAP designation, enhanc...
Spire Healthcare Surges Amid Reports of Potential Acquisition by Narayana Health
November 29, 2024 11:37 AM GMT| By Team Kalkine MediaHighlights:,Narayana Health Eyes Control:,India’s Narayana Health reportedly in talks to acquire a controlling stake in Spire Healthcare.,Potential Takeover Premium:,Narayana may pursue 75% ownership and consider taking Spire private.,Share Price Sur...
Argent BioPharma to Delist from LSE, Redirects Focus to ASX and US Markets
November 29, 2024 09:19 AM GMT| By Team Kalkine MediaHighlights:,LSE Delisting Announced:,Argent BioPharma plans to delist from the London Stock Exchange by December 31, 2024.,Shift to Core Markets:,Focus will shift to the company's primary listings on the ASX and OTCQB in the US.,Cost Efficiency Aim:,...
Aptamer Group PLC Eyes Licensing Opportunities Amid Strategic Advances
November 29, 2024 08:26 AM GMT| By Team Kalkine MediaHighlights:,Extended Cash Runway:,Recent funding secures a strong financial position for future licensing opportunities.,Strategic Collaborations:,Partnerships with AstraZeneca, Unilever, and others advance milestone projects in medicine and consumer...
ECO Animal Health Reports 13% Revenue Drop But Sees Growth in Key Markets
November 28, 2024 10:27 AM GMT| By Team Kalkine MediaHighlights,Revenue Decline:,Group revenue decreased by 13% to £33.2 million, with a constant currency decrease of 9%.,Operational Growth in Key Markets:,Revenue in the USA and Canada increased by 5%, while Latin America saw an 8% growth.,Strategic Mo...
Allergy Therapeutics Delivers Higher-Than-Expected EPS for Full Year 2024
November 28, 2024 08:59 AM GMT| By Team Kalkine MediaHighlights:,Allergy Therapeutics reports a 7.4% decrease in revenue for the full year 2024.,Net loss narrows by 6.6%, with an improved loss per share compared to FY 2023.,The company’s revenue is forecast to grow 19% annually over the next two years,...
Spire Healthcare Increases Shareholder Value with Share Repurchase
November 28, 2024 08:16 AM GMT| By Team Kalkine MediaHighlights:,Spire Healthcare has completed the purchase of 44,939 shares under its ongoing share buyback program.,The share buyback is part of Spire Healthcare’s strategy to enhance shareholder value and optimize capital structure.,Following the repu...
Oxford Nanopore Technologies Partners with UK Biobank for Groundbreaking Epigenetics Study
November 27, 2024 03:34 PM GMT| By Team Kalkine MediaHighlights,Innovative Research:,Oxford Nanopore will analyze 50,000 UK Biobank samples to investigate disease mechanisms through epigenetic sequencing.,Cutting-Edge Technology:,Comprehensive methylation marker insights provided without complex chemic...
Oxford Nanopore and UK Biobank Work Together on Epigenetic Innovation
November 27, 2024 08:39 AM GMT| By Team Kalkine MediaHighlights:,Oxford Nanopore Technologies collaborates with UK Biobank to develop the world’s largest epigenetic dataset.,The initiative will involve 50,000 participant samples aimed at advancing research in disease mechanisms, especially cancer and d...
GSK’s Liquid Meningitis Vaccine Cleared by EU Authorities
November 27, 2024 08:34 AM GMT| By Team Kalkine MediaHighlights:,GSK’s liquid meningitis vaccine, Menveo, has received approval from the European Commission for use in children, adolescents, and adults.,The liquid formulation eliminates the need for reconstitution, simplifying the vaccination process.,...
AstraZeneca PLC (AZN) attracts hedge fund attention for its cancer treatment potential
November 25, 2024 10:36 AM GMT| By Team Kalkine MediaHighlights:,Cancer remains one of the leading global health challenges, with millions of new cases and deaths reported annually.,Pharmaceutical and biotech companies are advancing cancer therapies, including innovations in radiopharmaceuticals and mR...
Renalytix plc Financial Performance for First Quarter of Fiscal Year 2025 Released
November 20, 2024 01:56 PM GMT| By Team Kalkine MediaHighlights:,Continued test ordering growth at a prominent New York-based physician group practice.,Cash burn reduced to an approximate monthly rate by the end of fiscal year 2025.,Financing commitments completed, providing a strengthened cash positio...
SkinBioTherapeutics and Croda Finalize Partnership for SkinBiotix Commercial Launch
November 19, 2024 12:48 PM GMT| By Team Kalkine MediaHighlights:,Commercial Partnership Secured:,SkinBioTherapeutics to receive royalties on global sales of Croda’s products utilizing SkinBiotix technology.,Innovative Cosmetics Platform:,Extensive testing reveals enhanced benefits of SkinBiotix, elevat...
GSK’s linerixibat successfully meets primary study endpoint
November 19, 2024 12:34 PM GMT| By Team Kalkine MediaHighlights:,GSK's linerixibat candidate shows positive results in Phase III trial for cholestatic pruritus in primary biliary cholangitis (PBC).,The trial met its primary endpoint with a statistically significant improvement in itch relief over 24 we...
LungLife AI Advances Commercialisation of Lung Cancer Diagnostic Test
November 19, 2024 12:04 PM GMT| By Team Kalkine MediaHighlights:,Positive Reception for LungLB:,Doctors in the Early Access Program report encouraging feedback, with orders placed and integration evaluations underway.,Medicare Coverage Application Pending:,LungLife AI aims to submit its MolDx program a...
Revolutionizing Medicine: The Expanding Frontier of mRNA Technology
November 19, 2024 10:51 AM GMT| By Team Kalkine MediaHighlights:,mRNA’s Broad Potential:,Beyond COVID-19 vaccines, mRNA technology is revolutionizing treatments for cancer and infectious diseases.,BioNTech and Moderna Lead the Way:,Both companies showcase unique strengths, from BioNTech's oncology focu...
SkinBioTherapeutics plc (SBTX:AIM) Finalizes Commercial Agreement with Croda Beauty Care for SkinBiotix™ Technology
November 19, 2024 07:42 AM GMT| By Team Kalkine MediaHighlights:,Commercial terms finalized with Croda, based on successful results from additional clinical studies.,SkinBioTherapeutics expects to be cash flow positive from FY2025, with no further capital raises required.,CEO Stuart Ashman to discuss t...
